Verity & Verity, LLC Abb Vie Inc. Transaction History

Verity & Verity, LLC

$875 Million
Q2 2024

A detailed history of Verity & Verity, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Verity & Verity, LLC holds 154,069 shares of ABBV stock, worth $31.4 Million. This represents 3.02% of its overall portfolio holdings.

Number of Shares

154,069

Previous 158,882 3.03%

Holding current value

$31.4 Million

Previous $27.3 Million 3.03%

% of portfolio

3.02%

Previous 3.03%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Sep 16, 2024	SELL	$154.79 - $180.76 $745,004 - $869,997	-4,813 Reduced 3.03%	154,069 $26.4 Million
Q2 2024 Aug 08, 2024	BUY	$154.79 - $180.76 $24.6 Million - $28.7 Million	158,882 New	158,882 $27.3 Million
Q1 2024 Sep 16, 2024	SELL	$159.82 - $182.1 $1.26 Million - $1.44 Million	-7,903 Reduced 4.97%	150,979 $27.5 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $300,380 - $338,299	2,183 Added 1.36%	163,136 $25.3 Million
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $304,585 - $352,602	2,280 Added 1.44%	160,953 $24 Million
Q2 2023 Jul 10, 2023	BUY	$132.51 - $164.9 $2.16 Million - $2.69 Million	16,307 Added 11.45%	158,673 $21.4 Million
Q1 2023 May 02, 2024	BUY	$144.61 - $166.54 $20.6 Million - $23.7 Million	142,366 New	142,366 $22.7 Million
Q1 2023 Apr 03, 2023	BUY	$144.61 - $166.54 $348,220 - $401,028	2,408 Added 1.72%	142,366 $22.7 Million
Q4 2022 Jan 11, 2023	BUY	$138.31 - $165.87 $786,983 - $943,800	5,690 Added 4.24%	139,958 $0
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $509,326 - $584,164	3,795 Added 2.91%	134,268 $18 Million
Q2 2022 Jun 30, 2022	SELL	$137.62 - $174.96 $30,414 - $38,666	-221 Reduced 0.17%	130,473 $20 Million
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $205,492 - $254,958	1,557 Added 1.21%	130,694 $21.2 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $2.81 Million - $3.55 Million	26,112 Added 25.35%	129,137 $17.5 Million
Q3 2021 Nov 04, 2021	BUY	$106.4 - $120.78 $301,750 - $342,532	2,836 Added 2.83%	103,025 $12.1 Million
Q2 2021 Sep 20, 2021	SELL	$105.21 - $117.21 $20,726 - $23,090	-197 Reduced 0.2%	100,189 $11.3 Million
Q1 2021 Jun 21, 2021	BUY	$102.3 - $112.62 $893,385 - $983,510	8,733 Added 9.53%	100,386 $11.4 Million
Q4 2020 Jan 12, 2021	BUY	$80.49 - $108.67 $750,327 - $1.01 Million	9,322 Added 11.32%	91,653 $9.99 Million
Q3 2020 Oct 06, 2020	BUY	$85.91 - $100.83 $198,366 - $232,816	2,309 Added 2.89%	82,331 $7.24 Million
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $146,593 - $196,163	1,998 Added 2.56%	80,022 $7.83 Million
Q1 2020 Apr 09, 2020	BUY	$64.5 - $97.79 $961,114 - $1.46 Million	14,901 Added 23.61%	78,024 $5.95 Million
Q4 2019 Jan 08, 2020	BUY	$72.13 - $90.25 $21,639 - $27,075	300 Added 0.48%	63,123 $5.59 Million
Q3 2019 Oct 11, 2019	BUY	$62.98 - $75.72 $298,525 - $358,912	4,740 Added 8.16%	62,823 $4.61 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $150,255 - $192,062	2,287 Added 4.1%	58,083 $4.22 Million
Q1 2019 Apr 29, 2019	BUY	$77.14 - $90.79 $356,849 - $419,994	4,626 Added 9.04%	55,796 $4.5 Million
Q4 2018 Jan 16, 2019	BUY	$77.85 - $96.01 $357,720 - $441,165	4,595 Added 9.87%	51,170 $4.72 Million
Q3 2018 Oct 16, 2018	BUY	$88.91 - $98.84 $81,352 - $90,438	915 Added 2.0%	46,575 $4.41 Million
Q2 2018 Jul 20, 2018	SELL	$89.78 - $106.23 $55,663 - $65,862	-620 Reduced 1.34%	45,660 $4.32 Million
Q2 2018 Jul 20, 2018	BUY	$89.78 - $106.23 $55,663 - $65,862	620 Added 1.36%	46,280 $4.29 Million
Q1 2018 Apr 25, 2018	SELL	$92.01 - $123.21 $63,854 - $85,507	-694 Reduced 1.5%	45,660 $4.32 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $103,173 - $113,137	1,152 Added 2.55%	46,354 $4.48 Million
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $3.16 Million - $4.03 Million	45,202	45,202 $4.02 Million

Others Institutions Holding ABBV

# of Institutions

3,767

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $360B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Verity & Verity, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verity & Verity, LLC with notifications on news.

Account

Verity & Verity, LLC Abb Vie Inc. Transaction History